MODERNA, INC.

MRNA
Real-time Estimate Quote. Real-time Estimate  - 01/20 11:34:23 am
122.87USD -1.71%

Turn to zoom
Prev.125.0100
Open124.5100
High126.0101
Low122.3500
Volume16 528 897
Latest news
19m ago
1h ago
1h ago
5h ago
Chart MODERNA, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBullishBullish
Resistance137170157
Spread/Res.-10%-28%-22%
Spread/Supp.18%26%144%
Support10498,050,5
Financials
Sales 2020 511 M - -
Net income 2020 -561 M - -
Net cash 2020 2 597 M - -
P/E ratio 2020 -104x
Yield 2020 -
Capitalization 49 468 M 49 468 M -
EV / Sales 2020 91,7x
EV / Sales 2021 4,18x
Nbr of Employees 1 100
Free-Float 90,0%
Company
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for infectious, autoimmune and cardiovascular diseases. Turnover per type of income can be broken down as follows:
- Collaboration revenue (79.8%);
- Grant revenue (20.2%).
At the end...

>> Read more
Sector :
Biotechnology & Medical Research - NEC
Calendar :
2021-03-10 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 136,60 $
Last Close Price 125,01 $
Spread / Highest target 48,0%
Spread / Average Target 9,27%
Spread / Lowest Target -44,8%